Abnormalities in Catecholamines and the Pathophysiology of Bipolar Disorder

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Unknown venue

• Publication date

  2007-05-14

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.3109/9781420021158-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Down-regulation of cortical β-adrenoceptors by chronic treatment with functional NMDA antagonists

  2007cited by this paper
• Serotonergic influence on the growth hormone response to clonidine in rat

  2005cited by this paper
• Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat

  2005cited by this paper
• Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia

  2005cited by this paper
• A Linkage Study Between the GABAA β2 and GABAAγ2 Subunit Genes and Major Psychoses

  2005cited by this paper
• The GABA type A receptor α5 subunit gene is associated with bipolar I disorder

  2005cited by this paper
• Effects of acute and chronic desipramine treatment on somatostatin receptors in brain

  2005cited by this paper
• Changes in hippocampal GABAA receptor subunit composition in bipolar 1 disorder.

  2005cited by this paper
• Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study.

  2005cited by this paper
• MRI analysis of cerebellar vermal abnormalities in bipolar disorder.

  2005cited by this paper
• Central noradrenaline depletion antagonizes aspects ofd-amphetamine-induced hyperactivity in the rat

  2004cited by this paper
• Possible association between a haplotype of the GABA-A receptor alpha 1 subunit gene (GABRA1) and mood disorders.

  2004cited by this paper
• Brain metabolic alterations in medication-free patients with bipolar disorder.

  2004cited by this paper
• Chronic Lithium Administration Enhances Noradrenergic Responses to Intravenous Administration of the α2 Antagonist Idazoxan in Healthy Volunteers

  2004cited by this paper
• Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.

  2004cited by this paper
• Increased inositol-monophosphatase activity by lithium treatment in bipolar patients.

  2004cited by this paper
• Secondary mania caused by caffeine.

  2003cited by this paper
• MRI investigation of temporal lobe structures in bipolar patients.

  2003cited by this paper
• Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography. Part II: Amphetamine-Induced Dopamine Release in the Functional Subdivisions of the Striatum

  2003cited by this paper
• Growth hormone and prolactin response to apomorphine in bipolar and unipolar depression.

  2003cited by this paper
• A Polymorphism of the Norepinephrine Transporter Gene in Bipolar Disorder and Schizophrenia: Lack of Association

  2002cited by this paper
• PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania.

  2002cited by this paper
• Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder.

  2002cited by this paper
• PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium.

  2002cited by this paper
• Excess of allele1 for α3 subunit GABA receptor gene (GABRA3) in bipolar patients: a multicentric association study

  2002cited by this paper
• Quantification of Neuroreceptors in Living Human Brain. V. Endogenous Neurotransmitter Inhibition of Haloperidol Binding in Psychosis

  2001cited by this paper
• Lack of association between GABRA3 and unipolar affective disorder: a multicentre study.

  2001cited by this paper
• Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness

  2001cited by this paper
• Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism

  2001cited by this paper
• Mania Associated with an Energy Drink: The Possible Role of Caffeine, Taurine, and Inositol

  2001cited by this paper
• Association Studies of Candidate Genes in Bipolar Disorders

  2000cited by this paper
• The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3

  2000cited by this paper
• Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients.

  2000cited by this paper
• An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia.

  2000cited by this paper
• MRI Analysis of the Cerebellum in Bipolar Disorder: A Pilot Study

  1999cited by this paper
• Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder.

  1999cited by this paper
• Subgenual cingulate cortex volume in first-episode psychosis.

  1999cited by this paper
• Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker?

  1999cited by this paper
• Tyrosine hydroxylase polymorphism and phenotypic heterogeneity in bipolar affective disorder: a multicenter association study.

  1999cited by this paper
• Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.

  1999cited by this paper
• Mania: gender, transmitter function, and response to treatment.

  1999cited by this paper
• Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder

  1998cited by this paper
• Preliminary evidence of an association between bipolar disorder in females and the catechol‐O‐methyltransferase gene

  1998cited by this paper
• Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele

  1998cited by this paper
• The brain, circadian rhythms, and clock genes

  1998cited by this paper
• Striatal Extracellular Dopamine Levels in Rats with Haloperidol-Induced Depolarization Block of Substantia Nigra Dopamine Neurons

  1998cited by this paper
• The modulation of corticoaccumbens transmission by limbic afferents and dopamine: a model for the pathophysiology of schizophrenia.

  1998cited by this paper
• Insertion/deletion variant (−141C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder

  1998cited by this paper
• GABA function in mood disorders: an update and critical review.

  1998cited by this paper
• The effects of lithium on a potential cycling model of bipolar disorder.

  1998cited by this paper
• Neuroprotective and neurorestorative properties of GDNF

  1998cited by this paper
• Neurobiology of lithium: an update.

  1998cited by this paper
• Learning by neurones: role of attention, reinforcement and behaviour.

  1998cited by this paper
• Norepinephrine-dopamine interactions in the prefrontal cortex and the ventral tegmental area: relevance to mental diseases.

  1998cited by this paper
• Clinical Studies on the Use of Lamotrigine in Bipolar Disorder

  1998cited by this paper
• Reduced [3H]Cyclic AMP Binding in Postmortem Brain from Subjects with Bipolar Affective Disorder

  1997cited by this paper
• Towards a neuropathology of emotion and mood

  1997cited by this paper
• I-123 iofetamine single-photon computed emission tomography in rapid cycling bipolar disorder: a clinical study.

  1997cited by this paper
• Linkage disequilibrium between the dopamine transporter gene (DAT1) and bipolar disorder: Extending the transmission disequilibrium test (TDT) to examine genetic heterogeneity

  1997cited by this paper
• Quantification of Neuroreceptors in the Living Human Brain: IV. Effect of Aging and Elevations of D2-Like Receptors in Schizophrenia and Bipolar Illness

  1997cited by this paper
• Subgenual prefrontal cortex abnormalities in mood disorders

  1997cited by this paper
• The basal ganglia and cognitive pattern generators.

  1997cited by this paper
• No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene.

  1997cited by this paper
• The anatomy of mood disorders--review of structural neuroimaging studies.

  1997cited by this paper
• Lack of association between bipolar disorder and tyrosine hydroxylase

  1997cited by this paper
• Dopamine neurons and their role in reward mechanisms.

  1997cited by this paper
• Bipolar disorder: Dominant or recessive on chromosome 5?

  1997cited by this paper
• Genetic association between monoamine oxidase and manic-depressive illness: comparison of relative risk and haplotype relative risk data.

  1997cited by this paper
• No abnormality in the gene for the G protein stimulatory alpha subunit in patients with bipolar disorder.

  1997cited by this paper
• Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes.

  1996cited by this paper
• Enhanced protein kinase C activity and translocation in bipolar affective disorder brains.

  1996cited by this paper
• Genetic association between monoamine oxidase A microsatellite and RFLP alleles and bipolar affective disorder: analysis and meta-analysis.

  1996cited by this paper
• Dopamine reverses the depression of rat corticostriatal synapses which normally follows high-frequency stimulation of cortex in vitro.

  1996cited by this paper
• Initiation and adaptation: a paradigm for understanding psychotropic drug action.

  1996cited by this paper
• Poststroke bipolar affective disorder: clinical subtypes, concurrent movement disorders, and anatomical correlates.

  1996cited by this paper
• A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures

  1996cited by this paper
• Limbic Dysfunction in Schizophrenia and Mania

  1996cited by this paper
• Further tests for linkage of bipolar affective disorder to the tyrosine hydroxylase gene locus on chromosome 11p15 in a new series of multiplex British affective disorder pedigrees.

  1996cited by this paper
• Receptor‐Mediated Activation of G Proteins Is Increased in Postmortem Brains of Bipolar Affective Disorder Subjects

  1996cited by this paper
• Opposite Modulation of Cocaine-Seeking Behavior by D1- and D2-Like Dopamine Receptor Agonists

  1996cited by this paper
• Preliminary confirmation of the proposed link between reward-dependence traits and norepinephrine.

  1996cited by this paper
• Premenstrual Dysphonias: Myths and Realities

  1995cited by this paper
• Single‐Photon Emission Computed Tomography of the Brain in Acute Mania and Schizophrenia

  1995cited by this paper
• In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.

  1995cited by this paper
• T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis.

  1995cited by this paper
• A weak association between TH and DRD2 genes and bipolar affective disorder in a Spanish sample.

  1995cited by this paper
• Association of biogenic amine metabolites with symptomatology in delusional (psychotic) and nondelusional depressed patients.

  1995cited by this paper
• Antidepressant-induced mania and cycle acceleration: a controversy revisited.

  1995cited by this paper
• Glutamate receptor dysfunction and schizophrenia.

  1995cited by this paper
• Evidence for a genetic association between alleles of monoamine oxidase A gene and bipolar affective disorder.

  1995cited by this paper
• No evidence of linkage or association between tyrosine hydroxylase gene and affective disorder.

  1995cited by this paper
• A molecular model for bipolar affective disorder.

  1995cited by this paper
• Anatomic and Behavioral Aspects of Frontal‐Subcortical Circuits a

  1995cited by this paper
• Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments

  1995cited by this paper
• Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3.

  1994cited by this paper
• Biogenic amine metabolites in delusional (psychotic) depression and melancholia subtypes of major depression.

  1994cited by this paper
• Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.

  1994cited by this paper
• Long‐term action of lithium: A role for transcriptional and posttranscriptional factors regulated by protein kinase C

  1994cited by this paper
• Dopamine D2 receptors in depression measured with single photon emission computed tomography.

  1994cited by this paper
• Cerebral cortex β-adrenoceptor binding in bipolar affective disorder

  1994cited by this paper

• Lithium monotherapy associated clinical improvement effects on amygdala-ventromedial prefrontal cortex resting state connectivity in bipolar disorder.

  2018cites this paper
• The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

  2015cites this paper
• Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D 1H MRS investigation.

  2013cites this paper
• Resting state corticolimbic connectivity abnormalities in unmedicated bipolar disorder and unipolar depression.

  2009influential citation
• Antidepressant Effect on Connectivity of the Mood-Regulating Circuit: An fMRI Study

  2005cites this paper